SD-169 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as an inhibitor targeting specific pathways involved in cell proliferation and survival. Researchers employ SD-169 to investigate its potential in disrupting the growth of cancer cells, especially in cases where traditional treatments have shown limited efficacy. Its application extends to preclinical studies, where it aids in understanding the molecular mechanisms underlying tumor development and progression. Additionally, SD-169 is explored for its role in combination therapies, aiming to enhance the effectiveness of existing anticancer drugs. Its use in laboratory settings contributes to the development of novel therapeutic strategies, offering hope for more targeted and efficient cancer treatments.